1800-272-662
Shopping Cart 0
countryflagAU
Login

Cann Group Ltd

Healthcare AU CAN

0.007AUD
-(-%)

Last update at 2026-03-13T05:10:00Z

Day Range

0.0070.007
LowHigh

52 Week Range

0.0060.03
LowHigh

Fundamentals

  • Previous Close 0.007
  • Market Cap11.12M
  • Volume619373
  • P/E Ratio0.70
  • Dividend Yield-%
  • EBITDA-7.23900M
  • Revenue TTM11.31M
  • Revenue Per Share TTM0.02
  • Gross Profit TTM 5.16M
  • Diluted EPS TTM0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -22.34500M -51.24200M -33.79000M -26.46800M -25.10300M
Minority interest - - - - -
Net income -22.34500M -51.24200M -33.79000M -26.46800M -25.10300M
Selling general administrative 3.72M 30.44M 33.19M 25.13M 21.45M
Selling and marketing expenses 9.60M 13.91M - - -
Gross profit 5.15M -21.75500M 13.78M 6.41M 4.25M
Reconciled depreciation - 11.04M 11.96M 4.80M 2.63M
Ebit -16.38100M -46.57300M -29.96100M -24.64000M -20.95200M
Ebitda -8.94100M -35.53600M -18.00100M -19.84300M -18.32100M
Depreciation and amortization 7.44M 11.04M 11.96M 4.80M 2.63M
Non operating income net other - - - - -
Operating income -8.94200M -27.50100M -29.72600M -24.24700M -19.27000M
Other operating expenses 22.20M 42.87M -51.26600M -35.87800M -29.42400M
Interest expense 6.00M 6.82M 3.16M 1.83M 4.15M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 5.96M 6.88M 4.43M 2.22M 0.04M
Net interest income - -6.81900M -3.15800M -1.82800M -4.11000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - -2.15000M 9.78M 6.26M 6.70M
Total revenue 13.25M 15.37M 13.78M 6.41M 4.29M
Total operating expenses 14.10M 42.87M 50.36M 35.48M 27.79M
Cost of revenue 8.10M 37.13M - - 0.05M
Total other income expense net -13.40300M -23.74100M 5.95M 4.43M 2.55M
Discontinued operations - - - - -
Net income from continuing ops - -51.24200M -33.79000M -26.46800M -25.10300M
Net income applicable to common shares -22.34500M -51.24200M -33.79000M -26.46800M -25.10300M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 78.79M 92.77M 129.47M 139.66M 101.79M
Intangible assets 0.00900M - 0.21M 0.79M 1.39M
Earning assets - - - - -
Other current assets 4.63M 0.35M 2.60M 1.64M 1.90M
Total liab 81.56M 78.93M 70.20M 54.76M 9.92M
Total stockholder equity -2.77500M 13.84M 59.26M 84.90M 91.87M
Deferred long term liab - - - - -
Other current liab 3.97M 2.65M 0.43M 0.16M 0.14M
Common stock 187.95M 182.90M 177.37M 169.43M 149.67M
Capital stock - - 177.37M 169.43M 149.67M
Retained earnings -191.81800M -169.47200M -118.23000M -84.44000M -61.16400M
Other liab - - 0.14M 0.10M 0.25M
Good will - - - 0.67M 0.66M
Other assets - - 0.51M 0.09M 0.09M
Cash 0.01000M 1.64M 0.77M 1.91M 3.10M
Cash and equivalents - - 0.77M 1.91M 3.10M
Total current liabilities 80.92M 78.25M 24.39M 11.30M 9.65M
Current deferred revenue - 0.18M 0.82M 0.81M 0.77M
Net debt 75.83M 70.91M 60.20M 45.25M -2.42500M
Short term debt 75.37M 72.05M 15.29M 3.80M 0.41M
Short long term debt - - 15.29M 3.50M -
Short long term debt total 75.84M 72.55M 60.97M 47.16M 0.68M
Other stockholder equity - - -59.13800M -84.98500M -88.50900M
Property plant equipment - - 107.40M 118.20M 76.43M
Total current assets 9.57M 16.26M 21.20M 19.17M 22.09M
Long term investments - - 0.14M 0.74M 1.22M
Net tangible assets - - 59.05M 83.44M 89.83M
Short term investments - - - - -0.08500M
Net receivables 0.59M 4.08M 5.64M 4.16M 4.20M
Long term debt - - 45.67M 43.36M 0.00000M
Inventory 4.34M 10.19M 12.20M 11.46M 12.89M
Accounts payable 1.57M 3.38M 7.85M 6.52M 8.33M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 1.09M 0.41M 0.12M -0.08200M 3.36M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 0.04M -107.75000M 0.09M -79.61500M
Deferred long term asset charges - - - - -
Non current assets total 69.22M 76.51M 108.26M 120.50M 79.70M
Capital lease obligations - - - 0.30M 0.68M
Long term debt total - - 45.67M 43.36M 0.27M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments - 1.18M -0.02800M -45.16400M -0.81400M
Change to liabilities - - 1.87M -3.97100M 3.24M
Total cashflows from investing activities -0.15700M 1.18M -0.02800M -45.16400M -17.08400M
Net borrowings - 10.36M 13.80M 46.48M -0.44700M
Total cash from financing activities 8.17M 14.77M 21.71M 64.41M 39.47M
Change to operating activities - - -0.74000M 0.26M -1.05400M
Net income -22.34500M -51.24200M -33.79000M -26.46800M -25.10300M
Change in cash -1.63000M 0.88M -1.14900M -1.19100M 1.55M
Begin period cash flow 1.64M 0.77M 1.91M 3.10M 1.55M
End period cash flow 0.01000M 1.64M 0.77M 1.91M 3.10M
Total cash from operating activities -9.64300M -15.18500M -22.83500M -20.43300M -20.83000M
Issuance of capital stock - 4.46M 7.92M 17.92M 40.20M
Depreciation 7.44M 11.04M 11.60M 4.46M 2.45M
Other cashflows from investing activities 0.00000M 3.68M 3.07M 0.00000M -0.81400M
Dividends paid - - - - -
Change to inventory 4.20M 1.25M -0.46300M 1.44M -2.85200M
Change to account receivables 1.31M 2.28M -2.10000M 0.06M -4.10400M
Sale purchase of stock 2.83M 4.46M 7.92M 17.92M -0.28600M
Other cashflows from financing activities 0.75M -0.04500M 17.30M 46.48M -0.44700M
Change to netincome - - 0.42M 3.46M 6.42M
Capital expenditures 0.16M 2.50M 3.10M 45.16M 16.27M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 5.04M 5.29M -2.56300M 1.50M -6.95600M
Stock based compensation 0.33M 0.18M 0.19M 0.74M 0.58M
Other non cash items -0.09800M 19.56M -0.64500M 1.58M 1.82M
Free cash flow -9.80000M -17.69000M -25.93600M -65.59700M -37.10000M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CAN
Cann Group Ltd		 - -% 0.007 0.70 - 0.98 0.32 2.69 0.85
AFP
Aft Pharmaceuticals Ltd		 - -% 3.00 23.08 19.88 1.35 3.81 1.72 13.67
VLS
Vita Life Sciences Ltd		 -0.02 0.80% 2.48 13.89 42.73 1.46 2.42 1.24 6.53
SNT
Syntara Ltd		 -0.001 3.33% 0.03 - 20.45 6.32 4.62 6.32 -2.1607
MVP
Medical Developments International Ltd		 0.005 1.23% 0.41 - 166.67 1.14 0.83 0.75 11.48

Reports Covered

Stock Research & News

View All

Profile

Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.

Cann Group Ltd

23 Greentek Court, Mildura, VIC, Australia, 3501

Key Executives

Name Title Year Born
Mr. Peter Crock M.B.A., MBA Chief Exec. Officer NA
Ms. Deborah Ambrosini B.Com., F.C.A. CFO & Company Sec. 1974
Mr. Shane Duncan Chief Operating Officer NA
Mr. Geoff Aldred Chief Projects & Information Officer NA
Mr. Clive Fanning Head of Investor Relations NA
Mr. Steven Notaro Head of Legal NA
Mr. Peter Koetsier Chief Executive Officer NA
Mr. Steven Notaro BA, J.D. Head of Legal and Regulatory Affairs & Company Secretary NA
Mr. Peter Koetsier Chief Executive Officer NA
Mr. Steven Notaro BA, J.D. Head of Legal and Regulatory Affairs & Company Secretary NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.